Filter Search


Healthcare and Medical


Location Summary Deadline
Poland Adaptation Of New Rooms For The Central Sterilization Room At The Provincial Hospital In Poznan, Carried Out In The Design, Build And Equip Formula 2026-07-16
Poland Modernization Of The Pulmonary Diseases Department 2026-07-16
Poland Delivery Of Infusion Fluids And Specialized Nutritional Preparations 2026-07-16
Finland Invitation To Market Dialogue 2026-07-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Liraglutide, Atc A10bj02 For The Period March 1, 2026 - February 29, 2028 (plus Extension Option 1x12 Months). 2026-07-17
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Period From 01.03.2026 To 29.02.2028, With An Additional Option For 12 Months. Ezetimib, Atorvastatin 2026-07-17
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Estradiol + Dienogest For The Period From 01.03.2026 To 29.02.2028 (plus Extension Option For 1x12 Months). Estradiol, Dienogest 2026-07-17
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Ws Ezetimib + Atorvastatin (excluding Package Size 90 Pieces) For The Period 01.03.2026 - 29.02.2028 (plus V-option 1x12 Months) 2026-07-17
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Liraglutide, Atc A10bj02 For The Period 01.03.2026 - 29.02.2028 (plus Extension Option 1x12 Months) 2026-07-17
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Estradiol + Dienogest, Atc G03ab08 For The Period 01.03.2026 - 29.02.2028 (plus Extension Option 1x12 Months) 2026-07-17
Whats app